2-Benzodioxinylaminoethanols: a new class of beta-adrenergic blocking and antihypertensive agents. 1981

L Lalloz, and V Loppinet, and G Coudert, and G Guillaumet, and B Loubinoux, and C Labrid, and M Beaughard, and G Dureng, and J C Lamar

Various 2-benzodioxinylaminoethanol derivatives were synthetized and investigated for beta-adrenergic blocking activity. Most compounds demonstrated a beta-blocking activity of a competitive type when evaluated in guinea pig atrial and tracheal preparations. Three compounds were more potent than practolol and propranolol. All compounds demonstrated antihypertensive properties in spontaneously hypertensive rats. The most active compound was 1-(1,4-benzodioxin-2-yl)-2-[N4-(2-methoxyphenyl)piperazino]ethanol (11), which at 2.5 mg/kg iv lowered blood pressure by 41%.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D009200 Myocardial Contraction Contractile activity of the MYOCARDIUM. Heart Contractility,Inotropism, Cardiac,Cardiac Inotropism,Cardiac Inotropisms,Contractilities, Heart,Contractility, Heart,Contraction, Myocardial,Contractions, Myocardial,Heart Contractilities,Inotropisms, Cardiac,Myocardial Contractions
D011922 Rats, Mutant Strains Rats bearing mutant genes which are phenotypically expressed in the animals. Mutant Strains Rat,Mutant Strains Rats,Rat, Mutant Strains,Strains Rat, Mutant,Strains Rats, Mutant
D004147 Dioxins A family of compounds that contain the 1,4-dioxin structure. Many specific dioxin derivatives are listed as CARCINOGENS; TERATOGENS; or MUTAGENS. Dioxin
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic

Related Publications

L Lalloz, and V Loppinet, and G Coudert, and G Guillaumet, and B Loubinoux, and C Labrid, and M Beaughard, and G Dureng, and J C Lamar
June 1979, Journal of medicinal chemistry,
L Lalloz, and V Loppinet, and G Coudert, and G Guillaumet, and B Loubinoux, and C Labrid, and M Beaughard, and G Dureng, and J C Lamar
November 1979, Journal of medicinal chemistry,
L Lalloz, and V Loppinet, and G Coudert, and G Guillaumet, and B Loubinoux, and C Labrid, and M Beaughard, and G Dureng, and J C Lamar
October 1978, Journal of medicinal chemistry,
L Lalloz, and V Loppinet, and G Coudert, and G Guillaumet, and B Loubinoux, and C Labrid, and M Beaughard, and G Dureng, and J C Lamar
September 1970, Journal of medicinal chemistry,
L Lalloz, and V Loppinet, and G Coudert, and G Guillaumet, and B Loubinoux, and C Labrid, and M Beaughard, and G Dureng, and J C Lamar
January 1985, Journal of cardiovascular pharmacology,
L Lalloz, and V Loppinet, and G Coudert, and G Guillaumet, and B Loubinoux, and C Labrid, and M Beaughard, and G Dureng, and J C Lamar
March 1976, Current therapeutic research, clinical and experimental,
L Lalloz, and V Loppinet, and G Coudert, and G Guillaumet, and B Loubinoux, and C Labrid, and M Beaughard, and G Dureng, and J C Lamar
January 1982, Journal of emergency nursing,
L Lalloz, and V Loppinet, and G Coudert, and G Guillaumet, and B Loubinoux, and C Labrid, and M Beaughard, and G Dureng, and J C Lamar
September 1982, Midwife, health visitor & community nurse,
L Lalloz, and V Loppinet, and G Coudert, and G Guillaumet, and B Loubinoux, and C Labrid, and M Beaughard, and G Dureng, and J C Lamar
March 1967, The New England journal of medicine,
L Lalloz, and V Loppinet, and G Coudert, and G Guillaumet, and B Loubinoux, and C Labrid, and M Beaughard, and G Dureng, and J C Lamar
January 1967, Duodecim; laaketieteellinen aikakauskirja,
Copied contents to your clipboard!